Mechanical Regulation of Bone Homeostasis Through p130Cas-mediated Alleviation of NF-κB Activity by Miyazaki, T. et al.
Miyazaki et al., Sci. Adv. 2019; 5 : eaau7802     25 September 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
1 of 14
P H Y S I O L O G Y
Mechanical regulation of bone homeostasis through 
p130Cas-mediated alleviation of NF-B activity
T. Miyazaki1,2*§, Z. Zhao3,4*, Y. Ichihara5,6*, D. Yoshino3,7, T. Imamura6, K. Sawada3,8, S. Hayano9, 
H. Kamioka9, S. Mori1, H. Hirata3†, K. Araki3, K. Kawauchi3‡, K. Shigemoto1, S. Tanaka10, 
L. F. Bonewald11, H. Honda12, M. Shinohara5,13, M. Nagao5, T. Ogata5, I. Harada8, Y. Sawada3,5,8,14§
Mechanical loading plays an important role in bone homeostasis. However, molecular mechanisms behind the 
mechanical regulation of bone homeostasis are poorly understood. We previously reported p130Cas (Cas) as a 
key molecule in cellular mechanosensing at focal adhesions. Here, we demonstrate that Cas is distributed in the 
nucleus and supports mechanical loading–mediated bone homeostasis by alleviating NF-B activity, which would 
otherwise prompt inflammatory processes. Mechanical unloading modulates Cas distribution and NF-B activity 
in osteocytes, the mechanosensory cells in bones. Cas deficiency in osteocytes increases osteoclastic bone resorption 
associated with NF-B–mediated RANKL expression, leading to osteopenia. Upon shear stress application on cultured 
osteocytes, Cas translocates into the nucleus and down-regulates NF-B activity. Collectively, fluid shear stress–
dependent Cas-mediated alleviation of NF-B activity supports bone homeostasis. Given the ubiquitous expression 
of Cas and NF-B together with systemic distribution of interstitial fluid, the Cas–NF-B interplay may also underpin 
regulatory mechanisms in other tissues and organs.
INTRODUCTION
Mechanical forces are integral to normal cellular functions (1), disrup-
tion of which leads to loss of homeostasis. Although bones are known 
to respond to mechanical loading (2), molecular mechanisms under-
lying mechanical regulation of bone homeostasis are poorly understood.
The ubiquitously expressed adaptor molecule p130Cas (Crk- 
associated substrate, hereafter referred to as Cas), which is phosphoryl-
ated at focal adhesions upon extracellular matrix engagement, is 
involved in various cellular processes including migration, survival, 
transformation, and invasion (3). We previously demonstrated that 
Cas functions as an ion channel–independent cytoskeletal mecha-
nosensor through force-dependent conformational changes (4, 5). 
However, it remains unclear whether Cas is involved in responses 
to mechanical forces in vivo.
Nuclear factor B (NF-B) is a transcription factor that plays a 
central role in regulating inflammation and aging (6). The classical 
NF-B pathway involves activation of the IB (inhibitor of B) kinase 
(IKK) complex, which induces degradation of IB, the inhibitor 
protein that masks nuclear localization signals of NF-B molecules 
and sequesters them in the cytoplasm (7). In addition to being 
phosphorylated and translocated into the nucleus, RelA/p65 (a subunit 
of NF-B, hereafter referred to as RelA) is subjected to acetylation. 
Whereas several lysine residues of RelA have been shown to be acety-
lated, acetylation at Lys310 is required for the complete transcriptional 
activity of NF-B (8). Because NF-B is also ubiquitously expressed 
and reportedly mechanoresponsive (9), we speculated that Cas might 
interact with NF-B in the mechanical regulation of organismal 
homeostasis related to inflammation and aging.
Interstitial fluid is distributed throughout the entire body of all 
animals and comprises most extracellular fluid, occupying about 
four times as much volume as compared to circulating blood plasma. 
The skeleton, which is a metabolically active organ undergoing con-
tinuous remodeling, is not completely solid but a deformable porous 
body containing interstitial fluid. Several factors, including Earth’s 
gravity and physical exercise, apply mechanical load to the skeletal 
system and maintain bone mass (10). Osteocytes are the most com-
mon cells in mature bones (11). In lamellar bone, osteocytes and their 
highly interconnective dendritic processes reside inside spaces called 
lacunae and canaliculi, respectively. Bone deformation, which results 
from mechanical loading, generates an interstitial fluid flow in the 
lacuno-canalicular system inducing a shear stress on osteocytes (12). 
Ablation of osteocytes revealed their roles in bone metabolism and 
response to mechanical unloading (13). Their regulatory role is also 
highlighted by the fact that osteocytes secrete paracrine and systemic 
regulators that affect osteoblast-mediated bone formation and 
osteoclast-mediated bone resorption (14). Together, we hypothesized 
that the Cas–NF-B interaction in osteocytes might be involved in 
mechanical regulation of bone homeostasis.
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RESULTS
Cas and NF-B are mechanically modulated in osteocytes 
in vivo and in vitro
To test our hypothesis on mechanical roles of Cas and NF-B in 
bone metabolism, we used a mouse bone-unloading model, in which 
one of the hindlimbs of each individual mouse was subjected to sciatic 
and femoral nerve resection, while the other was exposed to a sham 
operation to serve as a control (15). Unloaded femurs exhibited a 
significant reduction of bone volume as compared to their contra-
lateral controls (Fig. 1A). Unexpectedly, a substantial proportion of 
Cas was distributed in the nuclei of osteocytes in control bones, 
whereas most Cas was observed in the cytosol of osteocytes in un-
loaded bones (Fig. 1B). Furthermore, acetylation of RelA, which 
correlates with NF-B activity (8), was increased in osteocytes of 
unloaded tibiae as compared to their contralateral controls (Fig. 1C, 
left and center). Notably, nuclear distribution of RelA in osteocytes 
was not significantly altered by unloading (Fig. 1C, right). Together, 
mechanical loading–dependent Cas nuclear distribution appeared 
inversely correlated with RelA acetylation in the nuclei of osteocytes. 
These in vivo findings suggest that Cas and NF-B may be involved 
in the previously reported mechanosensory function of osteocytes 
(13) and contribute to mechanical loading–related bone homeostasis.
Simulative studies indicate that osteocytes are exposed to fluid 
shear stress (FSS) with a peak magnitude of 0.8 to 3 Pa, which arises 
from interstitial fluid flow in canaliculi generated upon mechanical 
loading on bones (12). Whereas nuclear distribution of Cas appeared 
minimal in MLO-Y4 osteocytes grown under static conditions, it 
significantly increased after applying pulsatile FSS (1 Pa on average, 
1 Hz) for 10 min and remained increased even 24 hours after termi-
nation of FSS (Fig. 1D). In contrast, RelA acetylation decreased 
after FSS application and remained decreased for at least 24 hours 
(Fig. 1E). Furthermore, when Cas expression was retrovirally silenced 
in MLO-Y4 osteocytes (Fig. 1F), FSS did not decrease but rather 
increased RelA acetylation (Fig. 1G, compare lanes 2 and 4, and 
Fig. 1H). These results suggest that Cas mediates shear stress–induced 
attenuation of RelA acetylation via nuclear translocation in osteo-
cytes in vitro.
Increased bone resorption and receptor activator of NF-B 
ligand expression in osteocyte-specific Cas knockout mice
To determine whether Cas and NF-B played physiological roles in 
regulating osteocytes’ function in vivo, we generated osteocyte-specific 
Cas conditional knockout mice (referred to herein as Cas cKO mice), 
which had markedly reduced Cas expression in osteocytes (Fig. 2A). 
Consistent with the inverse correlation between Cas nuclear distri-
bution and RelA acetylation in the control and unloaded bones of 
wild-type (WT) mice (Fig. 1, B and C), we observed enhanced RelA 
acetylation, but not nuclear distribution, in osteocytes of Cas cKO 
mice (Fig. 2B). Although Cas cKO mice were born with no evident 
bone phenotype and developed normally with no apparent morpho-
logical abnormalities (fig. S1, A and B), 10-week-old Cas cKO mice 
exhibited significantly decreased bone volume and cortical thickness 
and increased cortical porosity (Fig. 2, C and D). Histomorphometric 
analysis revealed a significant increase in bone resorption (Fig. 2E) 
with unaltered bone formation (fig. S2) in Cas cKO mice. Further-
more, the expression level of sclerostin, a negative regulator of osteo-
blast proliferation and differentiation secreted by osteocytes (16), 
remained unchanged in bones of Cas cKO mice (Fig. 2F). Bone 
resorption is affected by the balance between receptor activator of 
NF-B ligand (RANKL), a differentiation factor for osteoclasts (17), 
and osteoprotegerin (OPG), a decoy receptor that interferes with 
the binding of RANKL to its signal-transducing receptor RANK (18). 
Therefore, increased RANKL/OPG ratio, resulting from the increase 
in RANKL expression with the unaltered OPG expression in Cas cKO 
bones (Fig. 2F), accounts for their enhanced bone resorption (Fig. 2E). 
All in all, these results indicate that Cas primarily controls osteo-
clastic bone resorption through its regulation of RANKL expression 
in osteocytes.
Cas mediates mechanical loading–induced  
suppression of osteoclastic bone resorption and  
RANKL expression in osteocytes
To examine whether the bone loss exhibited in Cas cKO mice was 
relevant to mechanical regulation, we conducted mechanical un-
loading experiments. Unloaded bones of control mice exhibited 
significant reduction of bone volume (Fig. 3A) with significantly 
increased bone resorption parameters as compared to their con-
tralateral controls (Fig. 3B). Although there was a significant de-
crease of bone volume in unloaded hindlimbs of Cas cKO mice 
(Fig. 3A, center), the extent of the unloading effect on bone volume 
was moderate and significantly less prominent in Cas cKO mice as 
compared to that in control mice (Fig. 3A, right). Notably, we did 
not observe significant differences in bone resorption parameters 
between control and unloaded bones of Cas cKO mice (Fig. 3B).
In control mice, RANKL mRNA expression in osteocyte frac-
tions prepared from unloaded bones was increased as compared 
to those from their contralateral control bones (Fig. 3C, columns 1 
and 2). However, RANKL expression in osteocyte fractions from 
Cas cKO mice was enhanced regardless of unloading (Fig. 3C, col-
umns 3 and 4).
It is likely that bone formation reduced upon unloading (19) in 
both control and Cas cKO mice, contributing to their decrease in 
bone volume (Fig. 3A). Although we observed a similar tendency of 
reduced bone formation parameters in both control and Cas cKO 
mice, we were unable to detect significant differences between the 
control and unloaded bones in either of them due to a large variability 
within each parameter (fig. S3A).
In agreement with the in vivo results (Fig. 3C), RANKL expres-
sion was reduced in MLO-Y4 osteocytes 24 hours after FSS applica-
tion (Fig. 3D, lanes 1 and 2), whereas it was significantly up-regulated 
in Cas-knockdown osteocytes irrespective of FSS (Figs. 1F and 3D, 
columns 3 and 4). These findings suggest that Cas in osteocytes 
plays a significant role in mechanical loading–induced decrease in 
RANKL-mediated bone resorption.
Cas is involved in mechanical loading–induced suppression 
of RelA acetylation in osteocytes
We next examined whether Cas was involved in the increase of 
RelA acetylation in osteocytes of unloaded bones. Consistent with 
our observations in WT mice (Fig. 1, B and C), Cas nuclear distri-
bution was decreased and RelA acetylation was increased in the 
osteocytes of unloaded tibiae as compared to those of their contra-
laterals of control Cas flox/flox mice (Fig. 3, E and F, and fig. S3B). 
However, RelA acetylation, but not nuclear distribution, was en-
hanced in those of Cas cKO mice regardless of unloading (Fig. 3, E to G). 
This suggests that Cas is involved in the mechanical loading–dependent 
decrease in RelA acetylation in osteocytes, supporting the physio-
logical relevance of the Cas–NF-B interplay.
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Fig. 1. Cas and NF-B are mechanically modulated in osteocytes in vivo and in vitro. (A) Reduction in bone mass by hemilateral hindlimb unloading. Representative 
microcomputed tomography (CT) images of mouse distal femurs are shown. Scale bar, 1 mm. (B) Loading-dependent change of Cas distribution in osteocytes in vivo. Confocal 
images of anti-Cas immunofluorescence (green) and nuclear [4′,6-diamidino-2-phenylindole (DAPI), blue] staining of osteocytes in midshaft tibiae are shown together with 
their DIC (differential interference contrast) images (left). The lower panels show higher-magnification images from regions highlighted by boxes in the upper panels. Scale bars, 
10 m. Quantitation of the nuclear distribution of Cas (right, n = 4 mice; each value was averaged from four to six osteocytes analyzed in each bone). (C) Increased RelA 
acetylation in osteocytes of unloaded bones. Confocal images of anti–acetylated RelA (acetyl-RelA, green), anti-RelA (RelA, red), and nuclear (DAPI) staining of osteocytes in 
midshaft tibiae are shown (left). Scale bar, 10 m. RelA acetylation (center) and nuclear distribution (right) were quantified. RelA acetylation was scaled with the mean value 
of control bones (column 1) set at 1 (n = 3 mice per group, each value was averaged from four to six osteocytes analyzed in each bone). (D and E) FSS-induced increase of 
Cas nuclear distribution and decrease of RelA acetylation in MLO-Y4 osteocytes. Confocal images of anti-Cas (D, green), anti–acetylated RelA (E, green), and anti-RelA 
(E, red) immunofluorescence and nuclear (DAPI) staining of MLO-Y4 osteocytes in static culture, immediately and 24 hours after 10-min pulsatile FSS. Scale bar, 20 m. 
Nuclear distribution of Cas was quantified as in (B) (n = 10 per group). (F) Cas-dependent decrease of RelA acetylation in MLO-Y4 osteocytes. RelA acetylation and phos-
phorylation in MLO-Y4 osteocytes infected with sh-Cas–expressing (sh-Cas) or its control (sh-control) retrovirus were analyzed by immunoblotting. Note that RelA phos-
phorylation was not affected by Cas knockdown. (G) Cas-dependent FSS-induced decrease of RelA acetylation in MLO-Y4 osteocytes. MLO-Y4 osteocytes with (sh-Cas) 
and without (sh-control) Cas knockdown, in static culture, and immediately or 24 hours after 10-min pulsatile FSS application, were analyzed by immunoblotting (top). 
The levels of RelA acetylation (acetyl-RelA/total RelA) were normalized against the static controls, which were set at 1 (bottom, n = 3). (H) Confocal images showing anti–
acetylated RelA (acetyl-RelA) (green) and anti-RelA (red) immunofluorescence in MLO-Y4 osteocytes, with (sh-Cas) and without (sh-control) Cas knockdown, in static 
culture (top) or immediately (middle) and 24 hours (bottom) after 10-min pulsatile FSS. Nuclei were stained with DAPI (blue). Scale bar, 20 m.
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Cas suppresses RANKL expression via down-regulation 
of RelA acetylation and intracellular reactive  
oxygen species level
Consistent with our in vivo findings from Cas cKO mice (Fig. 2F), 
Cas-knockdown MLO-Y4 osteocytes showed increased RANKL 
mRNA expression with no significant changes in sclerostin and OPG 
expressions (Fig. 4A). In addition, RelA acetylation was increased in 
both Cas cKO (Fig. 2B) and Cas-knockdown MLO-Y4 osteocytes (Fig. 1, 
F and G). Furthermore, RelA knockdown decreased RANKL expres-
sion, but not sclerostin or OPG, in MLO-Y4 osteocytes (Fig. 4B). These 
results indicate that suppression of RelA acetylation is responsible for 
Cas-dependent decrease in RANKL expression in MLO-Y4 osteocytes.
We next looked into the mechanism by which Cas–NF-B inter-
play regulated RANKL expression in osteocytes. As we could not detect 
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Fig. 2. Increased bone resorption and RANKL expression in osteocyte-specific Cas knockout mice. (A) Significant reduction of Cas expression in osteocyte fractions 
derived from Cas cKO mice. (B) Increased RelA acetylation in osteocytes of Cas cKO mice. Confocal images of anti–acetylated RelA (green) and anti-RelA (red) immunofluo-
rescence images of midshaft tibiae of Casflox/flox mice and Cas cKO mice are shown with nuclear staining (left). RelA acetylation (center) and nuclear distribution (right) 
were quantified as in Fig. 1C. RelA acetylation was scaled with the mean value of control bones (column 1) set at 1 (n = 3 mice per group; each value was averaged from 
four to six osteocytes analyzed in each bone). Scale bar, 10 m. (C) Reduced bone mass in Cas cKO mice. Representative radiographic images of the femurs (left; arrows 
point to apparent differences in bone density) and distal femur CT (center) of Cas cKO mice and normal Casflox/flox littermates are shown. Scale bars, 1 mm. The ratio of 
bone volume over total volume (BV/TV) was calculated from CT images (right, n = 5 mice per group). (D) Loss of cortical bone in Cas cKO mice. Representative CT images 
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histomorphometric analysis (n = 5 mice per group). (F) Increased RANKL expression in osteocytes of Cas cKO mice. mRNA expression levels of sclerostin, OPG, and RANKL as well as 
RANKL/OPG ratio in the osteocyte fractions derived from Casflox/flox and Cas cKO mice were normalized against data from Casflox/flox mice, which were set at 1 (n = 3 mice per group).
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the binding of RelA to the promoter region of the RANKL gene by 
chromatin immunoprecipitation (ChIP) analysis (fig. S4A), we postu-
lated that RANKL expression might not be directly induced by NF-B 
and tested for intracellular reactive oxygen species (ROS). Increased 
ROS has been shown to stimulate RANKL expression in cells of 
osteoblastic lineage (20), and several molecules downstream of the 
classical NF-B pathway, such as tumor necrosis factor– (TNF-), 
interleukin-1 (IL-1), NADPH (reduced form of nicotinamide 
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adenine dinucleotide phosphate) oxidase, and xanthine oxidase, 
enhance ROS production (21). ROS level was increased in Cas- 
knockdown MLO-Y4 osteocytes (Fig. 4C and fig. S4B), in which 
treatment with a ROS inhibitor, N-acetyl-l-cysteine (NAC), nullified 
the increase of RANKL expression (Fig. 4D). While silencing RelA 
alone moderately reduced RANKL expression (Fig. 4B), Cas knock-
down did not increase RANKL expression and intracellular ROS 
level in RelA-knockdown MLO-Y4 osteocytes (Fig. 4E, compare 
columns 2 and 4 in each graph). Furthermore, exogenous expres-
sion of WT RelA in MLO-Y4 osteocytes increased intracellular ROS 
level and RANKL expression as compared to the expression of 
RelA K310R, the acetylation-defective mutant of RelA (Fig. 4F, 
compare columns 2 and 3 in each graph). This suggests the contri-
bution of acetylation to RelA-mediated regulation of intracellular 
ROS level and RANKL expression in osteocytes. Collectively, 
these results show that Cas negatively regulates RelA acetylation, 
which, in turn, controls RANKL expression by increasing intra-
cellular ROS level in osteocytes.
Cas down-regulates NF-B activity by interfering 
with RelA-p300/CBP interaction in the nucleus
We next asked whether Cas affected the transcriptional activity of 
NF-B and conducted various exogenous expression experiments. 
Exogenous expression of Cas suppressed RelA acetylation in human 
embryonic kidney (HEK) 293 cells (Fig. 5A, lanes 2 and 3) as well as 
in Cas−/− mouse embryonic fibroblasts (MEFs) (Fig. 5B), and there-
fore, Cas-dependent suppression for RelA acetylation did not appear 
to be osteocyte specific. Luciferase assay revealed that overexpres-
sion of Cas led to a reduction in the NF-B transcriptional activity 
enhanced by overexpression of RelA (Fig. 5C). Furthermore, exog-
enous expression of Cas decreased expression levels of NF-B target 
genes, IL-8 and TNF-, both of which were increased by RelA over-
expression (Fig. 5D). In line with this, Cas overexpression alleviated 
TNF-–enhanced NF-B activity (Fig. 5E). In contrast, Cas knock-
down enhanced TNF-–induced NF-B activation (Fig. 5F) and 
expression of IL-8 and TNF- (Fig. 5G). Coexpression of Cas hampered 
NF-B activation by constitutively active form of IKK, IKKSS/EE 
(Fig. 5H) (22). Notably, not only WT Cas (CasWT) but also Cas15YF, 
in which 15 phosphorylation-defective mutations are introduced to 
the substrate domain (CasSD) (4), tempered the IKK-induced NF-B 
activation (Fig. 5H, top). These results indicate that Cas has an 
inhibitory effect downstream of the IKK complex in the NF-B 
activation cascade, without requiring CasSD phosphorylation.
Whereas both phosphorylation and acetylation of RelA occur 
downstream of IKK complex activation (8), IKK-induced acetyla-
tion, but not phosphorylation, of RelA was significantly mitigated by 
CasWT and Cas15YF (Fig. 5H, bottom). Consistently, introducing 
GFP (green fluorescent protein)–Cas to Cas−/− MEFs suppressed 
acetylation, but not phosphorylation, of RelA (Fig. 5B). Together, 
Cas down-regulates NF-B activity by inhibiting RelA acetylation.
We further tested whether the nuclear distribution of Cas was 
related to its attenuation of NF-B activity. Nuclear accumulation 
of Cas was observed after treatment with an inhibitor of nuclear 
export, leptomycin B (fig. S5A). In our biochemical analysis, Cas 
was detectable in the nuclear fraction. Furthermore, the extent of 
nuclear distribution was comparable between CasWT and Cas15YF 
(fig. S5B), both of which ameliorated NF-B activity and RelA 
acetylation (Fig. 5H). We next used nuclear export signal–attached 
Cas (NES-Cas) to determine whether translocation of Cas into the 
nucleus was necessary for its attenuation of NF-B activity. NES-Cas 
was hardly detectable in the nuclear fraction (fig. S5C), and impor-
tantly, NES-Cas attenuated neither RelA acetylation (Fig. 5A, lanes 2 
and 4) nor RelA-enhanced NF-B activity (Fig. 5I, columns 2 and 4). 
These results suggest that nuclear distribution is required for Cas to 
hinder RelA acetylation and subsequently to alleviate NF-B activity.
Although several lysine residues of RelA are known to be acetyl-
ated (23), only the mutation at Lys310 (K310R) rendered RelA resist-
ant to Cas-mediated suppression of NF-B activity (Fig. 5J and 
fig. S5D). This suggests that Lys310 of RelA (RelA K310) is the site of 
acetylation involved in the Cas-dependent modulation of NF-B activity.
p300/CBP, which is distributed exclusively in the nucleus, has 
been reported to mediate RelA K310 acetylation (24). Coexpression 
experiments revealed that both RelA and Cas were coimmunopre-
cipitated with p300 (Fig. 5K and fig. S5E). Furthermore, increasing 
Cas expression inversely correlated with the coimmunoprecipitation 
of RelA with p300 (Fig. 5K), whereas coexpression with RelA ham-
pered Cas-p300 coimmunoprecipitation (fig. S5E). In addition, 
endogenous RelA-p300 interaction was enhanced in Cas-knockdown 
MLO-Y4 osteocytes (Fig. 5L, compare lanes 2 and 3). Together with 
the inverse correlation between Cas nuclear distribution and RelA 
acetylation observed in osteocytes in vivo and in vitro (Fig. 1, B to E), 
these results suggest that nuclear Cas inhibits RelA acetylation by 
competing for interaction with p300/CBP in the nucleus.
Among various Cas truncation mutants (fig. S6A), those that con-
tained amino acids 672 to 738 such as Cas672-874 attenuated NF-B 
activity (fig. S6B) and coimmunoprecipitated with p300 (fig. S6C) 
similarly to full-length Cas. Furthermore, Cas672-874 appeared to 
interfere with the RelA-p300 interaction (fig. S6D, lanes 1 and 3). 
These results suggest that the amino acids 672 to 738 of Cas contain 
the region responsible for the inhibition of NF-B activity.
Physiological role of the Cas–NF-B interplay in bone 
homeostasis; consequences of Cas deletion in osteocytes are 
unaltered by heterozygous Rela deletion
Last, we analyzed Cas/Rela cKO mice to define the physiological rele-
vance of the Cas–NF-B interplay that we observed by these in vitro 
studies. To avoid enhanced apoptosis that has been shown to result 
from homozygous deletion of the Rela gene (25), we chose its het-
erozygous deletion. Whereas heterozygous Rela deletion alleviated 
bone loss caused by Cas knockout (Fig. 6A), the bone mass of het-
erozygous Rela cKO mice, which had intact Cas alleles, was not in-
creased as compared to their control mice (fig. S7A). This suggests 
that the positive effect of heterozygous deletion of the Rela gene on 
bone mass is specific for Cas cKO. Furthermore, increased bone re-
sorption parameters and RANKL expression in bones of Cas cKO 
mice were almost completely unaltered (Fig. 6, B and C) and bone 
formation parameters were not significantly altered (fig. S7B) by 
heterozygous deletion of the Rela gene. These in vivo results suggest 
that Cas–NF-B interplay plays a physiological role in regulating 
bone resorption via RANKL expression in osteocytes.
DISCUSSION
In this study, we demonstrate that Cas has a previously unidentified 
mechanoresponsive function whereby it translocates into the nucleus in 
response to shear stress and inhibits RelA acetylation. Deletion of 
full-length Cas withdraws not only this inhibitory effect on NF-B 
activity but also other Cas functions, including force-dependent 
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(NES)–attached Cas on RelA acetylation. HEK293 cells transfected with Cas, NES-Cas, or their control vector were analyzed by immunoblotting. (B) GFP-Cas–dependent 
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(E and F) Down-regulation of TNF-–induced NF-B activation by Cas. HEK293 cells cotransfected with pNF-B Luc and phRL-TK together with FLAG-Cas (E) or Cas-targeted 
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cytoskeletal association and phosphorylation (4, 5). Osteocyte-specific 
Cas KO mice may have mechanically relevant alterations arising in-
dependently of the NF-B hyperactivation, particularly in relation to 
defective Cas phosphorylation. However, the bone phenotype of Cas 
cKO mice that we observed with our analysis (Fig. 2) was unaltered 
by heterozygous Rela deletion (Fig. 6); the phenotype can therefore 
be accounted for by a defect in the Cas–NF-B interplay, which is 
distinct from Cas phosphorylation. Whereas the role of mechano-
responsive phosphorylation of Cas in bone homeostasis remains to 
be addressed, it may relate to other mechanosensory functions of 
osteocytes that do not involve suppression of NF-B activity such as 
is mentioned below.
We demonstrate that RANKL expression in osteocytes decreases 
upon mechanical loading in vivo and FSS application in vitro (Fig. 3, 
C and D). In contrast, mechanical stretching of MLO-Y4 osteocytes 
with a hyperphysiological magnitude (10,000 ) has been reported 
to increase RANKL expression (26). Although the physiological rel-
evance of this stretch-dependent increase of RANKL expression in 
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osteocytes is yet to be determined, it may involve Cas phosphoryl-
ation and hamper homeostasis-disrupting events such as ectopic 
bone formation.
FSS imposed on the endothelium, which arises from blood flow, 
has been shown to regulate normal and pathological vascular func-
tions, including morphogenesis, blood pressure, and atherosclerosis 
(27). The importance of FSS as a regulatory factor is not likely limited 
to the endothelium. Almost all cells in parenchymal tissues are bathed 
in interstitial fluid and can be exposed to FSS that arises from move-
ment of interstitial fluid. Here, we demonstrate the significance of 
FSS-induced alleviation of NF-B activity in bone metabolism. Given 
the ubiquitous expression of both Cas and NF-B as well as the sys-
temic distribution of interstitial fluid, shear stress–induced Cas- 
mediated down-regulation of NF-B may underpin the regulation 
of organismal homeostasis in general, particularly that related to 
physical activity.
Although we find that FSS enhances nuclear distribution of Cas 
(Fig. 1D), the mechanism regulating Cas shuttling between the cytosol 
and the nucleus remains to be elucidated. Cas molecules associate 
with stretched cytoskeletal complexes (28) and appear to change their 
localization depending on cytoskeletal tension, which is modulated 
by fluid flow–induced shear stress (29). Together with the recently 
reported mechanical regulation of nuclear transport through nuclear 
pores (30), nuclear distribution of Cas may relate to cytoskeletal 
tension. Several mechanoresponsive proteins that bind to Cas without 
requiring CasSD phosphorylation, including FAK (focal adhesion 
kinase), zyxin, and DOCK180, are known to shuttle between the 
cytoplasm and the nucleus (3, 31). Interactions with these proteins 
may regulate the nuclear distribution of Cas, while further study is 
required to determine its detailed mechanism.
Amino acids 672 to 738 of Cas appear to include the region that 
is critical for binding to p300 and inhibiting NF-B activity (fig. S6). 
Specific functions or interacting proteins of this region have yet 
to be reported. It has been shown that a C-terminal 31-kDa cleav-
age fragment of Cas is generated by caspase in apoptotic cells and 
translocated into the nucleus together with E2A protein (32). How-
ever, NES-Cas, in which NES was attached to the N terminus 
and thus the C terminus was not modulated, did not exhibit an 
inhibitory effect on NF-B transcriptional activity and RelA acety-
lation (Fig. 5, A and I). Therefore, it is unlikely that the C-terminal 
cleavage fragment of Cas is responsible for the suppression of 
NF-B activity.
Recent studies have revealed that mechanical forces are critical 
factors for vital cell processes (33) that underpin organismal func-
tions. Nonetheless, the importance of mechanical loads exerted 
on, or generated in, local tissues and organs is poorly understood. 
Physical exercise is broadly recognized to be highly potent as a ther-
apeutic or preventative procedure for numerous diseases and dis-
orders, particularly those related to aging, as exemplified by the 
effectiveness of aerobic exercise in health promotion (34). Although 
bodily activities during exercise mostly generate mechanical loads 
on local tissues, molecular mechanisms behind the beneficial effects 
of physical exercise or activity remain largely unexplored from a 
mechanical perspective. Our present study clarifies the importance of 
cellular responses to mechanical stress in physical activity–mediated 
tissue homeostasis. We speculate that responses of tissues and organs 
to local mechanical loads, which are generated during bodily motion, 
may underlie the essence of physical exercise or activity as a positive 
measure toward well-being.
MATERIALS AND METHODS
Mice
Casflox/flox and Rela flox/+ mice of C57BL/6 background (35, 36) were 
mated with Dmp1-Cre transgenic mice, in which the Cre recombinase 
gene was specifically expressed in osteocytes (37). Dmp1-Cre+/−, 
Cas flox/flox (Cas cKO) and Dmp1-Cre−/− Cas flox/flox (normal littermates) 
mice were generated by mating Dmp1-Cre−/−, Cas flox/flox male mice with 
Dmp1-Cre+/−, Cas flox/+ female mice. Dmp1-Cre+/−;Casflox/flox;Relaflox/+ 
(Cas/Rela cKO) and Dmp1-Cre−/−;Cas flox/flox;Relaflox/+ (normal litter-
mates) mice were generated by mating Dmp1-Cre+/−;Cas flox/flox;Rela +/+ 
male mice with Dmp1-Cre−/−;Cas flox/flox;Rela flox/+ female mice. Dmp1-Cre+/– 
Rela flox/+ (Rela cKO) and Dmp1-Cre−/−;Relaflox/+ (normal littermates) 
mice were generated by mating Dmp1-Cre+/−;Rela +/+ male mice with 
Dmp1-Cre−/−;Rela flox/flox female mice. All animals were housed under 
specific pathogen–free conditions and treated with humane care under 
approval from the Animal Care and Use Committee of Tokyo Metro-
politan Institute of Gerontology, National Rehabilitation Center for 
Persons with Disabilities, and Nadogaya Hospital. For all mouse analy-
ses except for those at 1 day after birth (fig. S1), male mice were used.
Cell lines
MLO-Y4 osteocytes (38) were maintained in -MEM (Minimum Essen-
tial Medium Alpha Modification, Wako, Osaka, Japan) with 2.5% FBS 
(fetal bovine serum; Life Technologies), 2.5% iron-supplemented 
calf serum (HyClone Laboratories, Logan, UT, USA), and penicillin 
(100 IU/ml)/streptomycin (100 g/ml) at 37°C. Cas-deficient MEFs 
and HEK293 cells (American Type Culture Collection, Manassas, 
VA, USA) were cultured in Dulbecco’s modified Eagle’s medium 
(Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% FBS 
and penicillin (100 IU/ml)/streptomycin (100 g/ml) at 37°C.
Analysis of bone phenotype
Radiography was performed using a high-resolution soft X-ray system 
(SOFTEX, Ebina, Japan). Microcomputed tomography (CT) scanning 
was performed using a ScanXmate-L090 scanner (Comscan Techno, 
Yokohama, Japan). Three-dimensional (3D) microstructural image 
data were reconstructed, and structural indices were calculated, using 
TRI/3D-BON and TRI/3D-BON-C software (RATOC Systems, Osaka, 
Japan). Bone histomorphometric analyses involving double calcein 
labeling were performed as described previously (39). Symbols and 
abbreviations used for histomorphometric parameters were as follows 
(40): ES, eroded surface; BS, bone surface; Oc.N, osteoclast number; 
Oc.S, osteoclast surface; O.Th, osteoid thickness; Ob.S, osteoblast 
surface; BFR, bone formation rate; MS, mineralizing surface. BFR/BS 
was calculated as MAR (mineral apposition rate) × MS/BS.
Plasmids
Expression vectors for RelA (pcDNA3-FLAG-RelA and pcDNA3- 
HA-RelA), NF-B–responsive reporter (pNF-B Luc), and Renilla 
luciferase expression (phRL-TK) vectors were described previously (41). 
The HA (hemagglutinin)–IKK expression vector was provided by 
H. Ichijo (The University of Tokyo, Japan). The HA-IKKSS/EE expres-
sion vector was constructed by site-directed mutagenesis. The expression 
vectors for FLAG-tagged Cas variants (Cas full-length, Cas15YF, 
Cas1-457, Cas1-638, Cas1-671, Cas1-738, Cas458-874, Cas639-874, 
Cas672-874, and Cas739-874) were constructed using pcDNA3-FLAG 
as a parent vector. The expression vector for p300 (CMV-p300-HA) (42) 
was a gift from R.H. Goodman (Oregon Health and Science University, 
OR, USA). The expression vector for NES-Cas was constructed by 
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cloning an NES sequence (MNLVDLQKKLEELELDEQQ) (43) 
attached Cas into pcDNA3. NF-B RelA K122/123R, K218R, K310R, 
and K314/315R were generated by site-directed mutagenesis and cloned 
into the pcDNA3-FLAG vector. The Myc-tagged RelA WT and 
K310R cloned in pcDNA3 (provided by J. Anrather) (44) were sub-
cloned into pBabe-hygromycin to construct the retroviral expression 
vectors for them.
Antibodies
Polyclonal anti-Cas antibody (catalog no. 06-500, RRID:AB_310144) 
was purchased from Millipore (Burlington, MA, USA). Monoclonal 
anti-Cas antibody (catalog no. 610271, RRID:AB_397666) was pur-
chased from BD Biosciences (San Diego, CA, USA). Monoclonal anti– 
-tubulin (catalog no. ICN691251, RRID:AB_2335130) and anti-FLAG 
(catalog no. P2983, RRID:AB_439685) were purchased from Thermo 
Fisher Scientific (Waltham, MA, USA) and Sigma-Aldrich (St. Louis, 
MO, USA), respectively. Monoclonal anti-HA (catalog no. MMS-101P, 
RRID:AB_2314672) and anti-Cre (catalog no. MMS-106P-200, RRID: 
AB_291267) antibodies were from Covance (Denver, PA, USA). 
Monoclonal anti-RelA (catalog no. sc-71676, RRID:AB_1126642), 
anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase; catalog 
no. sc-32233, RRID:AB_627679), anti-p300 (catalog no. sc-56455, 
RRID:AB_2262185), and anti–c-Myc (catalog no. sc-40, RRID: 
AB_627268) antibodies were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). Monoclonal anti–phosphorylated RelA (Ser536) 
(catalog no. 3033, RRID:AB_331284), monoclonal anti–histone H3 
(catalog no. 3638S, RRID: AB_1642229), and anti–-actin (catalog 
no. 4967, RRID:AB_330288) antibodies were purchased from Cell 
Signaling Technology (Beverly, MA, USA). Polyclonal anti–acetylated 
RelA (Lys310) antibodies (catalog no. 3045S, RRID:AB_823580; 
catalog no. ab19870, RRID:AB_776753) were purchased from Cell 
Signaling Technology and Abcam (Cambridge, MA, USA).
Cellular fractionation
The cytosolic and nuclear fractions were prepared, following a pro-
tocol published previously (45) with some modifications. Cells were 
washed with ice-cold phosphate-buffered saline (PBS) twice and in-
cubated with buffer A [10 mM Hepes·KOH (pH 7.9), 10 mM KCl, 
0.1 mM EDTA, 0.1 mM EGTA, 0.2% NP-40, 1 mM dithiothreitol 
(DTT), and protease inhibitor cocktail (Roche, Mannheim, Germany)] 
on ice for 10 min. Samples were then scraped, transferred to micro-
tubes, and homogenized with vigorous shaking. The cytosolic fraction 
was yielded by collecting the supernatant after two consecutive centrif-
ugations (1500g for 3 min followed by 20,000g for 10 min). The pellet 
after the first centrifugation was washed with wash buffer [10 mM 
Hepes·KOH (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 
1 mM DTT, and protease inhibitor cocktail] twice, and the resultant 
pellet was resuspended in buffer B [20 mM Hepes·KOH (pH 7.9), 
500 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and protease 
inhibitor cocktail], incubated on ice for 15 min, and homogenized with 
vigorous shaking. The nuclear fraction was yielded by collecting the 
supernatant after centrifugation at 20,000g for 10 min. To verify the 
nuclear/cytosolic fractioning and to obtain a loading control for each 
fraction, anti–histone H3 and anti–-tubulin immunoblottings were 
conducted (fig. S5, B and C).
Immunofluorescence staining
For cultured cells, cells were washed with ice-cold PBS, fixed with 
4% paraformaldehyde in PBS, permeabilized with 0.1% Triton 
X-100 in PBS, stained using anti-Cas and anti-RelA as primary anti-
bodies as well as Alexa Fluor 488 anti-rabbit immunoglobulin G (IgG) 
and Alexa Fluor 546 anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) 
as secondary antibodies, and then viewed with a confocal micro-
scope (Nikon A1R system). 4′,6-Diamidino-2-phenylindole (DAPI; 
Vector Laboratories, Burlingame, CA, USA) was used to stain the 
nucleus.
For osteocytes in mouse midshaft tibiae, mice were transcardially 
perfused with 4% paraformaldehyde in phosphate buffer (pH 7.4). 
Tibiae were immersed in the same fixative at 4°C overnight and de-
calcified in 10% EDTA (pH 7.4) at 4°C for 14 days. The samples 
were embedded in paraffin, sectioned with 5-m thickness, and in-
cubated with primary antibodies (anti-Cas, anti-RelA, and anti–
acetylated RelA) at 4°C overnight. Alexa Fluor 488–conjugated goat 
anti-mouse IgG, Alexa Fluor 488 anti-rabbit IgG, and Alexa Fluor 
594 anti-mouse IgG were used as secondary antibodies. Nuclei were 
counterstained using DAPI. Sections were mounted with Fluorescent 
Mounting Media (Dako, CA, USA). Quantitative 3D analysis of 
nuclear/total Cas was conducted using Imaris software (Bitplane, 
Zurich, Switzerland).
Coimmunoprecipitation to analyze association with p300
MLO-Y4 osteocytes or HEK293 cells were washed with ice-cold 
PBS, lysed with a lysis buffer [25 mM Hepes·Na (pH 7.2), 150 mM 
CH3COOK, 2 mM EDTA, 0.1% NP-40, 10 mM NaF, 1 mM DTT, 
and protease inhibitor cocktail] (46), scraped, and collected in a tube. 
After 10-min incubation on ice, samples were cleared of cell debris 
by centrifugation at 13,000g for 10 min and incubated with specific 
antibodies. Immunoprecipitation was conducted using PureProteome 
Magna Protein A Magnetic Beads (Millipore, Billerica, MA, USA) 
according to the manufacturer’s instruction, and proteins were re-
covered from resultant immunoprecipitates by 1× SDS sample buffer 
and subjected to SDS–polyacrylamide gel electrophoresis followed 
by immunoblotting.
RNA extraction and real-time reverse transcription 
polymerase chain reaction analysis
Total RNA was isolated using an RNA extraction kit (RNeasy, Qiagen 
or OMEGA Bio-Tech), and complementary DNA (cDNA), obtained 
using the First Strand cDNA Synthesis Kit (Qiagen or Fermentas), 
was amplified by quantitative polymerase chain reaction (PCR) us-
ing either QuantiTect SYBR Green PCR Master Mix (Qiagen) with 
a 7300 Real-Time PCR system (Applied Biosystems) or SsoFast 
EvaGreen Supermix with a CFX96 C1000 thermal cycler (Bio-Rad). 
All reactions were run in triplicate. The mRNA expression levels of 
individual genes were normalized to GAPDH or EF-1 (mouse) or 
-actin (human) expression.
Primer sequences used for PCR
Primer sequences used were as follows: mouse GAPDH, 5′-GGAT-
GCAGGGATGATGTTCT-3′ and 5′-AACTTTGCCATTGTG-
GAAGG-3′; mouse EF-1, 5′-TGCTGCCATTGTTGATATGG-3′ 
and 5′-TCCACAGCTTTGATGACACC-3′; mouse sclerostin, 
5′-TCCTGAGAAGAACCAGACCA-3′ and 5′-GCAGCTGTACT-
CGGACACATC-3′; mouse OPG, 5′-GTTTCCCGAGGACCACAAT-3′ 
and 5′-CCATTCAATGATGTCCAGGAG-3′; mouse RANKL, 
5′-CAAGCTCCGAGCTGGTGAAG-3′ and 5′-CCTGAACT-
TTGAAAGCCCCA-3′; human IL-8, 5′-CTTGGCAGCCTTCCT-
GATTT-3′ and 5′-TTCTTTAGCACTCCTTGGCAAAA-3′; human 
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TNF-, 5′-TCTTCTCGAACCCCGAGTGA-3′ and 5′-CCTCT-
GATGGCACCACCAG-3′; human -actin, 5′-GTACCACTGG-
CATCGTGATGGACT-3′ and 5′-CCGCTCATTGCCAATGGTGAT-3′.
Luciferase reporter assay
NF-B–responsive reporter plasmid (pNF-B Luc) and Renilla lucif-
erase expression plasmid (phRL-TK) were cotransfected with the in-
dicated expression plasmids into HEK293 cells. Twenty-four hours 
after transfection, cells were subjected to experiments. Luciferase 
activity was measured using the Dual-Glo Luciferase Assay System 
(Promega, Madison, WI, USA). Specific NF-B Luc activity in indi-
vidual samples was determined by normalizing firefly luciferase ac-
tivity to Renilla luciferase activity. For all assays, experiments were 
performed in triplicate.
RNA interference
Short hairpin RNA introduction by retroviral gene transfer
The retroviral vectors pSuper-sh-Cas puro and pSuper-sh-RelA 
puro were cloned with the mouse Cas target sequence 5′-GCATGA-
CATCTACCAAGTT-3′ and the mouse Rela target sequence 5′-GAAG-
AAGAGTCCTTTCAAT-3′, respectively, into a pSuper retro puro 
vector (Oligoengine, Seattle, WA). For double gene silencing of Cas 
and RelA, the retroviral vector pSuper-sh-RelA puro, in which the 
mouse Rela target sequence was cloned into a pSuper retro puro 
vector, was used together with pSuper-sh-Cas hygro. The plasmid 
harboring the retroviral construct was transiently transfected into 
the packaging cell line HEK293T or Plat-E (respectively provided 
by H. Ichijo and T. Kitamura, The University of Tokyo). Super-
natants containing retroviral particles were collected 24 to 48 hours 
after transfection and used immediately to infect cell cultures. Sub-
confluent MLO-Y4 osteocytes were exposed to viral supernatants in 
the presence of polybrene (6 g/ml) for 24 hours and then incubated 
in fresh culture medium for 2 days. Infected cells were selected by 
culturing them in the presence of puromycin (5 g/ml) for at least 
4 days. For double gene silencing, doubly infected cells were selected 
by culturing them in the presence of hygromycin (400 g/ml) and 
puromycin.
Small interfering RNA transfection
To silence the endogenous expression of Cas in HEK293 cells, 
Cas-targeted small interfering RNA (siRNA) (Stealth RNAi, BCAR1- 
HSS114273, Thermo Fisher Scientific) was transfected using Lipo-
fectamine RNAiMAX (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. Twenty-four hours after transfection, cells 
were used for experiments. Similar results were obtained using another 
Cas-targeted siRNA (Stealth RNAi, BCAR1-HSS114272, Thermo 
Fisher Scientific).
Biochemical analysis of osteocytes in vivo and in vitro
Muscle, connective tissue, and periosteum were removed from femurs 
and tibiae to separate osteocytes from whole bone, and the bones were 
cut at the metaphyses. Hematopoietic cells and osteoblastic cells 
were removed from the diaphyses of femurs and tibiae by flushing 
with PBS and using a microinterdental brush (0.2 mm in diameter). 
The remaining bone was used as a source of osteocyte-enriched cells. 
The osteocyte-rich bones were frozen in liquid nitrogen and ground 
into a powder using a tissue pulverizer. The powdered bone was then 
subjected to extraction of RNA, DNA, and protein. MLO-Y4 osteo-
cytes, MEFs, HEK293 cells, and osteocyte fractions were harvested, 
and cell lysates were biochemically analyzed.
Measurement of intracellular ROS level
The ROS level in MLO-Y4 osteocytes was measured using the DCFDA- 
Cellular Reactive Oxygen Species Detection Assay Kit (Abcam) ac-
cording to the manufacturer’s instruction.
FSS experiments
MLO-Y4 osteocytes were exposed to FSS of 1 Pa at a frequency of 
1 Hz, as described previously (47) with slight modifications. MLO-Y4 
osteocytes were cultured in a 60-mm plastic dish (Sumitomo Bakelite, 
Akita, Japan) precoated with 0.1% bovine gelatin (Sigma-Aldrich). 
The experiments were conducted 1 or 2 days after the cells were 
seeded. To expose MLO-Y4 cells to FSS, a parallel plate flow chamber 
and roller pump (HV-07523-80, Masterflex) were used. The flow 
chamber, which was composed of a cell culture dish, a polycarbonate 
I/O unit, and a silicone gasket, generated a 35-mm-long, 26.7-mm-
wide, 0.4-mm-high flow channel. The system was placed in a CO2 
incubator to maintain pH and temperature of culture medium.
ChIP assay
The ChIP assay was performed using the EZ-ChIP Kit from Millipore 
according to the manufacturer’s instruction. The primers used for 
the ChIP assay were as follows:
mouse RANKL, 5′-GAGTTCTAGAATTTCCCCAAG-3′ and 5′-GT-
GCCTCTTTCACTCCCACAT-3′ (48); mouse TNF-, 5′-TGTAC-
CGCAGTCAAGATATG-3′ and 5′-TGCCTGTGTCTATTTCCTTT-3′.
Hemilateral hindlimb unloading experiments
Hemilateral hindlimb neurectomy was conducted by surgically re-
secting 5- to 6-mm segments of sciatic and femoral nerves, as de-
scribed previously (15). As a control sham operation for neurectomy, 
the contralateral sciatic and femoral nerves were surgically exposed 
and left unresected. Neurectomy side (right or left) was chosen ran-
domly. Operations were performed 1 week (for biochemical and 
immunohistochemical studies) or 2 weeks (for CT and bone histo-
morphometric studies) before mice were sacrificed at the age of 
10 weeks, and subjected to analyses.
Statistical analysis
Statistical comparisons were performed with two-tailed unpaired t test 
or analysis of variance (ANOVA) followed by post hoc Bonferroni test 
using SPSS (IBM) software, and each series of experiments was re-
peated at least three times. P values <0.05 were considered statistically 
significant. For all figures and supplementary figures, quantitative 
data are presented as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001; 
NS, not significant by two-tailed unpaired t test unless specified 
otherwise. Adequate sample sizes of experiments were estimated on 
the basis of our pilot experiments and experience with similar measure-
ments to ensure adequate power to detect a specified effect size. For 
animal analyses, at least three animals were assigned to each experi-
mental group according to standard scientific conventions. We tried 
to reach a conclusion for each individual experiment, using as small 
a size of samples as possible. No data were excluded, whereas the 
investigators were not blinded to any group allocations, which were 
randomly performed for in vivo or in vitro experiments.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/9/eaau7802/DC1
Fig. S1. Skeletal phenotype of Cas cKO mice is not distinct at birth.
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Fig. S2. Bone formation parameters are not significantly altered in Cas cKO mice.
Fig. S3. Mechanical regulation of bone formation in control and Cas cKO mice and nuclear 
distribution of Cas in their osteocytes.
Fig. S4. ChIP analysis of RelA binding to the RANKL promoter region and measurement of 
intracellular ROS level.
Fig. S5. Cas suppresses RelA acetylation at Lys310 in the nucleus and alleviates NF-B activity 
without requiring phosphorylation of its substrate domain.
Fig. S6. Cas672-738 contains the region responsible for the inhibition of NF-B activity.
Fig. S7. Neither bone mass of mice with intact Cas alleles nor bone formation of Cas cKO mice 
is significantly altered by heterozygous deletion of Rela in osteocytes (Rela cKO).
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